drugset / Trial / NCT07301333
A Study of Single and Multiple Doses of HRS-6257 in Healthy Subjects
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a phase I, randomised, single-blind placebo-controlled, 2-part study to assess the safety, tolerability, pharmacokinetics, pharmacodynamics and food effect of single and multiple oral doses of HRS-6257 in healthy volunteers.
Timeline
- Start
- 2025-12-30
- Primary completion
- 2026-05
- Completion
- 2026-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HRS-6257 | Unknown | — | Oral |
Indications
No indication recorded.